Merck, Pfizer and Bristol-Myers Squibb Pharmaceutical Products Ahead of Earnings Results

Bristol-Myers Squibb Co. Coumadin brand medication, used to treat blood-clots, is arranged for a photograph at a pharmacy in Princeton, Illinois, U.S., on Monday, April 27, 2015. Bristol-Myers Squibb Co. is expected to release earnings on April 28. Photographer: Daniel Acker/Bloomberg via Getty Images
Bristol-Myers Squibb Co. Coumadin brand medication, used to treat blood-clots, is arranged for a photograph at a pharmacy in Princeton, Illinois, U.S., on Monday, April 27, 2015. Bristol-Myers Squibb Co. is expected to release earnings on April 28. Photographer: Daniel Acker/Bloomberg via Getty Images
Merck, Pfizer and Bristol-Myers Squibb Pharmaceutical Products Ahead of Earnings Results
COMPRAR UMA LICENÇA
Como posso utilizar esta imagem?
475,00 €
EUR

DETALHES

Restrições:
Contacte o representante local para todos os usos comerciais ou promocionais.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial #:
471365150
Coleção:
Bloomberg
Data da criação:
27 de abril de 2015
Data do upload:
Tipo de licença:
Inf. sobre autorização:
Não tem autorização. Mais informações
Fonte:
Bloomberg
Nome do objeto:
BMY EARNS
Tamanho máx.:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 3 MB